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Background: Shifts in body composition, such as accumulation of body fat, can be a symptom of many chronic
human diseases; hence, efforts have been made to investigate the genetic mechanisms that underlie body
composition. For example, a few quantitative trait loci (QTL) have been discovered using genome-wide association
studies, which will eventually lead to the discovery of causal mutations that are associated with tissue traits.
Although some body composition QTL have been identified in mice, limited research has been focused on the
imprinting and interaction effects that are involved in these traits. Previously, we found that Myostatin genotype,
reciprocal cross, and sex interacted with numerous chromosomal regions to affect growth traits.
Results: Here, we report on the identification of muscle, adipose, and morphometric phenotypic QTL (pQTL),
translation and transcription QTL (tQTL) and expression QTL (eQTL) by applying a QTL model with additive,
dominance, imprinting, and interaction effects. Using an F2 population of 1000 mice derived from the
Myostatin-null C57BL/6 and M16i mouse lines, six imprinted pQTL were discovered on chromosomes 6, 9, 10, 11,
and 18. We also identified two IGF1 and two Atp2a2 eQTL, which could be important trans-regulatory elements.
pQTL, tQTL and eQTL that interacted with Myostatin, reciprocal cross, and sex were detected as well. Combining
with the additive and dominance effect, these variants accounted for a large amount of phenotypic variation in
this study.
Conclusions: Our study indicates that both imprinting and interaction effects are important components of the
genetic model of body composition traits. Furthermore, the integration of eQTL and traditional QTL mapping may
help to explain more phenotypic variation than either alone, thereby uncovering more molecular details of how
tissue traits are regulated.
Keywords: eQTL mapping, QTL mapping, Body composition, Myostatin, Imprinting, Interaction, MouseBackground
With respect to complex traits (i.e., phenotypes controlled
by multiple genes), although people are still doubting the
importance of epistasis or gene by gene interation [1],
there is strong evidence that epistasis should not be
neglected when studying complex traits [2-4]. For example,
in mammals, coat color is controlled by interactions
among several genes [5]. Furthermore, Brockmann et al.* Correspondence: jreecy@iastate.edu
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reproduction in any medium, provided the or(2000) reported that epistasis could account for approxi-
mately 33-36% of the phenotypic variance observed in
body weight and fat accumulation and 20-33% of the vari-
ance in muscle weight and hormone serum concentra-
tions in mice. These results highlight the important role of
epistasis in the control of phenotypic traits. In addition to
the epistasis, imprinting effect is another important con-
tribution to the phenotypic variance in complex traits.
Cheverud et al. suggested that combing phenotype-based
mapping and bioinformatics approaches could help to
understand the mechanisms that underlie imprinting [6].Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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modifier genes and major genes, such as Myostatin, to
impact the expressivity of muscling phenotype. Myostatin
variants have been shown to enhance muscle growth in
cattle, dogs, mice, and humans [7-10]. In contrast to breeds
like Belgian Blue, some homozygous Myostatin-null South
Devon cattle do not exhibit the double-muscling phe-
notype [11]. Furthermore, we and others have reported the
identification of QTL that interact with Myostatin to
control growth and muscling in mice [12-14].
Multiple genomic regions associated with growth and
fatness were identified in pigs [15]. In humans, genetic
variation present in several chromosomal regions has
been associated with obesity traits [16-18]. Unfortu-
nately, the functional genes involved in body compos-
ition in these regions have not yet been identified. It has
been pointed out that transcriptome mapping [19] might
be a new method to identify other loci that control body
composition [20]. Transcriptome mapping, also called
“genetical genomics”, was first proposed by Jansen and
Nap [21]. They suggested that traditional quantitative
genetic approaches could be applied to genome-wide
gene expression data as a valuable approach towards the
identification of regulatory regions. This concept has
been successfully applied in more than a dozen species,
including mouse, maize, human, rat, eucalyptus, and
Arabidopsis thaliana [22-33]. Pomp et al. suggested that
transcriptome mapping might provide details about the
molecular mechanism of obesity QTL [20]; for example,
a QTL may be identified as a trans- or cis-regulator
based on its physical distance from the targeted gene.
In this study, we performed an extensive QTL mapping
experiment designed to evaluate multiple layers of genetic
regulation of body composition traits through the identifi-
cation of phenotypic QTL(pQTL), translation and tran-
scription QTL (tQTL), and expression QTL (eQTL). We
used an F2 population from the M16i mouse line and
C57BL/6 Myostatin-null mouse line. M16i is a polygenic
obese mouse line that was derived from an ICR mouse
line after selection for 3–6 week high body weight gain
[34]. M16i mice exhibit many typical obesity phenotypes
[35-38]. In contrast, the Myostatin-null mouse displays a
significant decrease in body fat accumulation with a
massive increase in skeletal muscle mass [39].
We measured ten muscle, adipose, and morphometric
phenotypes, six transcription and translation traits, and
nine gene expression traits. The nine genes studied here
were chosen based on the differentially expressed genes
in skeletal muscle from Myostatin-null versus Myostatin
wild-type mice that were identified from our previous
microarray experiment [40]. Additive, dominance, and
imprinted QTL models were evaluated with the aim of
identifying potential QTL. Interaction effects between
QTL and the Myostatin genotype, reciprocal cross, andsex were evaluated as well. In addition, the amount of
phenotypic variation accounted for by each QTL was
computed. Combined with the other growth trait QTL
that were identified in our previous study, these results
provide further information about how genetic variants
regulate body composition.Results
Data evaluation
Summary statistics for all phenotypic measurements are
presented in Additional file 1: Table S1, and pairwise
phenotypic correlations are presented in Additional file 1:
Table S2 and Additional file 2: Table S7. We observed high
correlations between most traits. For example, the two
adipose traits, adiposity index (AI) and fat pad weight
percentage (FAT), were significantly correlated (P < 0.05)
with all other traits.
The significant main and interaction effects identified
with PROC GLM were included as fixed effects in the
QTL model (Additional file 1: Table S3). In addition,
imprinting effects were also included. Details of these
models are discussed in the Methods section.Additive and dominance effects
We identified 20 and 40 non-imprinted QTL at 1% and
5% genome-wide significance levels, respectively, using an
additive and dominance QTL model (Table 1). Among
these 40 QTL, 38 were pQTL and two were eQTL.
We detected pQTL for all ten phenotypic traits
measured in this study, except for the soleus muscle
weight. The greatest number of pQTL was associated
with gastrocnemius weight, while only one pQTL each
was detected for body mass index (BMI) and tail length,
both located on chromosome 11. The 38 non-imprinted
pQTL were distributed across 13 chromosomes. No
pQTL were identified on chromosomes 4, 12, 13, 19,
and X. Chromosome 1 harbored the greatest number of
pQTL. The phenotypic variation accounted for by these
38 pQTL ranged from 0.86% to 9.88%. Interestingly, the
pQTL that were associated with pectoralis and gastro-
cnemius weights on chromosome 1 had the two largest
F-values. These two pQTL also explained the largest
amount of phenotypic variation (Table 1). QTL tended
to have larger additive than dominance effects, although
most additive and dominance effects were not large.
Two eQTL were identified at a 5% genome-wide signifi-
cance level (Table 1). The eQTL on chromosome 1 was
associated with Tnni1 expression level, whereas the eQTL
on chromosome 4 impacted IGF1 expression. Both eQTL
explained about 2% of the phenotypic variation. In this
context, we have found positional concordance between
eQTL located on chromosome 1 (23 cM) associated with
Tnni1 expression level and two pQTL associated with
Table 1 Statistics of non-imprinted QTL
Peak Flanking markersc Estimated
Chr Traita Groups (cM)b Left Right F-value LOD a s.ea d s.ed % var
e
1 Gastro** pQTL 23 rs3696088 rs13472794 35.40 14.84 −0.0417 0.0054 −0.0239 0.0073 6.73
1 Pec** pQTL 23 rs3696088 rs13472794 53.84 22.19 −0.0084 0.0089 −0.0503 0.0120 9.88
1 Tnni1 eQTL 23 rs3696088 rs13472794 8.73 3.75 −0.3433 0.0965 −0.2555 0.1282 2.23
1 AI** pQTL 24 rs3696088 rs13472794 13.00 5.57 0.0813 0.0165 0.0332 0.0219 2.64
1 Fat** pQTL 24 rs3696088 rs13472794 13.54 5.80 0.0817 0.0167 0.0367 0.0222 2.68
1 Edl** pQTL 25 rs3696088 rs13472794 7.19 3.10 −0.0327 0.0086 0.0010 0.0112 1.44
2 Edl pQTL 78 rs3144393 rs13476878 6.79 2.93 −0.0179 0.0052 0.0107 0.0082 1.36
2 Gastro** pQTL 80 rs3144393 rs13476878 9.40 4.04 −0.0117 0.0033 0.0124 0.0053 1.88
2 AI** pQTL 88 rs3144393 rs13476878 18.65 7.95 0.0519 0.0091 −0.0263 0.0138 3.65
2 Fat** pQTL 88 rs3144393 rs13476878 19.62 8.35 0.0535 0.0092 −0.0279 0.0140 3.84
3 Pec pQTL 44 rs13477174 rs3670634 9.84 4.23 0.0143 0.0049 0.0243 0.0069 1.96
3 Gastro pQTL 56 rs3663873 rs13477430 6.51 2.81 0.0084 0.0032 0.0134 0.0050 1.31
3 Edl pQTL 64 rs3663873 rs13477430 5.45 2.35 0.0179 0.0058 0.0145 0.0103 1.10
4 IGF1 eQTL 68 rs6324470 rs3659226 8.46 3.63 0.0985 0.0312 −0.1273 0.0516 2.17
5 Gastro pQTL 49 rs6256504 CEL-5_52953963 4.51 1.95 −0.0050 0.0030 0.0113 0.0048 0.91
6 Gastro pQTL 0 - rs13478602 6.64 2.86 −0.0058 0.0028 0.0125 0.0041 1.33
6 AI** pQTL 27 rs13478727 rs13478839 10.27 4.41 0.0393 0.0090 −0.0121 0.0136 1.99
6 Fat** pQTL 28 rs13478727 rs13478839 9.97 4.29 0.0394 0.0091 −0.0122 0.0137 1.98
6 lengthNT** pQTL 45 rs3676254 rs3656205 13.45 5.76 0.2921 0.0578 0.1200 0.0975 2.58
7 Gastro pQTL 47 rs3676254 rs3656205 5.65 2.44 0.0227 0.0068 −0.017 0.0073 1.14
7 Pec** pQTL 47 rs3676254 rs3656205 10.54 4.53 0.0445 0.0113 −0.0169 0.0122 2.10
8 Gastro pQTL 37 rs13479657 rs13479757 7.22 3.11 0.0134 0.0036 −0.0032 0.0060 1.45
8 Fat** pQTL 68 rs3678433 rs6182338 15.00 6.42 0.0556 0.0102 0.0022 0.0163 2.96
8 AI** pQTL 69 rs3678433 rs6182338 15.38 6.58 0.0546 0.0100 0.0032 0.016 2.95
9 Gastro pQTL 0 - rs13480071 4.28 1.85 −0.0039 0.0029 −0.0100 0.0039 0.86
9 AI pQTL 23 rs8259427 rs6213724 8.94 3.85 0.0311 0.0091 0.0334 0.0139 1.79
9 Fat pQTL 23 rs8259427 rs6213724 9.18 3.95 0.0320 0.0091 0.0336 0.0140 1.83
10 lengthNT pQTL 26 rs13480578 CEL-10_58149652 7.96 3.43 0.1970 0.0519 −0.0946 0.0792 1.58
10 Gastro pQTL 30 rs13480579 CEL-10_58149653 4.50 1.94 −0.0082 0.0028 −0.0033 0.0041 0.91
11 Tail** pQTL 25 rs6276300 rs6199956 16.87 7.21 0.2461 0.0425 0.024 0.0682 3.29
11 lengthNT** pQTL 26 rs6276300 rs6199956 21.55 9.16 0.3596 0.0556 0.0833 0.0892 4.15



















Table 1 Statistics of non-imprinted QTL (Continued)
11 Gastro pQTL 68 rs3653651 rs13481216 4.86 2.10 0.0086 0.0028 0.0026 0.0040 0.98
14 Gastro pQTL 34 rs8251329 rs3712401 7.77 3.35 0.0118 0.0030 0.0030 0.0042 1.56
17 AI** pQTL 17 rs13482893 rs3719497 11.2 4.81 0.0418 0.0091 −0.0079 0.0145 2.14
17 Fat** pQTL 17 rs13482893 rs3719497 10.94 4.70 0.0415 0.0091 −0.0097 0.0144 2.14
17 Edl** pQTL 33 rs3023442 rs6395919 7.74 3.34 −0.0187 0.0049 0.0072 0.0079 1.55
17 Gastro** pQTL 68 rs6257479 rs3663966 9.62 4.14 −0.0128 0.0029 0.0024 0.0042 1.92
18 lengthNT pQTL 34 rs3670254 rs3718618 8.39 3.62 0.2128 0.0522 0.0373 0.078 1.67
18 lengthNA pQTL 35 rs3670254 rs3718618 8.62 3.72 0.1345 0.0325 0.0149 0.0486 1.71
aTrait abbreviations: lengthNA nasal to anal length (cm), lengthNT nasal to tail length (cm), AI adiposity index, BMI body mass index, Tail tail length (cm), Soleus soleus muscle weight percentage, Gastro gastrocnemius
muscle weight percentage, Edl EDL muscle weight percentage, Pec pectoralis muscle weight percentage, Fat average gonadal fat pad weight percentage (epididymal for males and perimetrial for females). Tnni1
troponin I type 1 expression, IGF1 insulin-like growth factor 1 expression. QTL with an F-value that exceeded 1% genome-wide permutation threshold are denoted by **; QTL without ** exceeded 5% genome-wide
permutation threshold.
bPeak position of QTL detected in Kosambicentimorgans.
cFlanking markers (left and right) of the QTL peak. A“-“ notation denotes the end of the chromosome. See Additional file 1: Table S6 for marker information.
da: additive effect; s.ea: standard error of additive effect; d: dominance effect; s.ed: standard error of dominance effect.
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http://www.biomedcentral.com/1471-2156/14/103pectoralis and gastrocnemius weight, which were located
in the same chromosomal region.
No significant additive or dominance effects were
identified for the six transcription and translation traits
at a 5% genome-wide significance level.
Imprinting effect
Imprinted QTL with a comparison-wise P-value of less
than 0.05 were only detected for phenotypic traits
(Table 2). These pQTL were located on chromosomes 6,
9, 10, 11, and 18. Among these imprinted pQTL, three
were associated with nasal to anal length. The two
imprinted pQTL on chromosome 18 shared the same
peak position and were both associated with adipose traits.
The amount of variation accounted for by these pQTL
was very similar and ranged from 2.2-2.4% of the total
phenotypic variation. Theimprinted pQTL on chromo-
some 10 for nasal to anal length was plotted in Figure 1.
In general, the P-values associated with additive pQTL
were more significant than those associated with domin-
ance and imprinted pQTL (Additional file 1: Table S4).
Interactions with Myostatin genotype, reciprocal cross,
and sex
We identified 19 chromosomal positions that signifi-
cantly interacted with Myostatin genotype (comparison-
wise P-value < 0.05) (Table 3). In addition, another 20
and 16 QTL positions were detected that significantly
interacted with sex and reciprocal cross, respectively
(Tables 4 and 5). The first model (am + dm + im) tested
for additive, dominance, and imprinted QTL by Myosta-
tin genotype effects. The second model (am + dm) tested
additive and dominance QTL by Myostatin genotype
effects. The third model (am) estimated the P-value of
the additive QTL by Myostatin genotype effect. A major-
ity of the QTL that interacted with Myostatin genotype or
sex were associated with adipose traits (Tables 3 and 4).
Most of the QTL by Myostatin genotype, sex, or reciprocalTable 2 Statisticsof imprinted QTL with comparison-wise P-va
Peakb Flanking markersc
Chr Traita Groups (cM) Left Right
6 lengthNA pQTL 45 rs4226048 mCV24115224
9 Edl pQTL 1 rs13480071 rs13480109
10 lengthNA pQTL 58 rs13480754 rs13480776
11 lengthNA pQTL 23 rs6276300 rs6199956
18 AI pQTL 39 rs3670254 rs3718618
18 Fat pQTL 39 rs3670254 rs3718618
aTrait abbreviations are the same as in Table 1.
bPeak position of QTL detected in Kosambi centimorgans.
cFlanking markers (left and right) of the QTL peak. See Additional file 1: Table S6 fo
da: additive effect; s.ea: standard error of additive effect; d: dominance effect; s.ed: s
imprinting effect.
e%var: percentage of phenotypic variance that a given QTL position can account focross interactions were additive or dominant. One excep-
tion was that of the BMI pQTL on chromosome 14 that
significantly interacted with sex, which appeared to behave
in an imprinted fashion. Interestingly, this same chromo-
somal region interacted with Myostatin genotype, but in a
dominant manner. Another exception was a tail length
pQTL on chromosome 7 that interacted with reciprocal
cross in an imprinted fashion.
Significant interactions with Myostatin genotype, sex,
and reciprocal cross were also detected for expression
traits (Tables 3, 4 and 5 respectively). These eQTL were
located on chromosomes 1, 3, 6, 7, 8, and X. Similar to
the pQTL data, the P-values from three interaction tests
are presented, along with the phenotypic variation ex-
plained by these interaction models.
Using a comparison-wise P-value of less than 0.05, a
total of seven tQTL were identified for their significant
interaction with Myostatin genotype, sex, or reciprocal
cross (Tables 3, 4 and 5). Among these seven tQTL, five
of them interacted with reciprocal cross, one with Myos-
tatin genotype, and one with sex. The average variation
accounted for by these QTL was about 2.5%.
Genetic variation components
For each trait, the total amount of phenotypic variation
accounted for by additive, dominance, and imprinted QTL
is presented in Figure 2(A). For most traits, the largest
proportion of phenotypic variation could be accounted for
by additive and dominance QTL. Additive, dominance,
and interaction QTL effects explained almost equal
amounts of genotypic variation for BMI. In contrast, QTL
interactions could account for a large proportion of the
phenotypic variation in soleus weight. The amount of
phenotypic variation explained by imprinted QTL varied
from trait to trait and was relatively small for most traits.
In comparison to pQTL, the amount of phenotypic
variation accounted for by eQTL and tQTL was relatively
small.lue < 0.05
Estimated
a s.ea d s.ed i s.ei % var
e
0.1438 0.0361 0.0867 0.0609 −0.1492 0.0631 2.21
−0.0008 0.0046 −0.0080 0.0064 0.0528 0.0114 2.27
0.0679 0.0320 0.0693 0.0478 0.2329 0.0588 2.24
0.1488 0.0350 0.0921 0.0561 −0.1188 0.0566 2.48
0.0406 0.0093 −0.0114 0.0141 0.0315 0.0156 2.42
0.0411 0.0094 −0.0114 0.0142 0.0323 0.0157 2.36
r marker information.
tandard error of dominance effect; i: imprinting effect; s.ei: standard error of
r.
Figure 1 Identification of an imprinted pQTL on chromosome 10 at 58 cM that controls nasal to anal length. IMP: imprinted QTL model.
AD: additive and dominance QTL model. Vertical line indicates the position of the imprinted QTL.
Table 3 Statistics of QTL that interact with Myostatin genotype
Position Flanking markersc am + dm+ imd am + dme amg
Chr Traita Groups (cM)b Left Right P-value %var P-value %var P-value % var
1 BMI pQTL 22 rs3696088 rs13472794 7.35E-02 0.70 3.85E-02 0.65 8.48E-03 0.69
1 Gastro pQTL 24 rs3696088 rs13472794 2.45E-08 3.58 1.77E-08 3.34 1.49E-01 0.20
1 Pec pQTL 25 rs3696088 rs13472794 3.95E-12 5.06 1.08E-11 4.56 3.52E-03 0.80
2 P/D tQTL 61 rs13476636 rs3144393 2.66E-04 2.64 1.56E-04 2.43 1.52E-04 2.00
3 Pec pQTL 43 rs13477174 rs3670634 2.31E-02 0.95 1.02E-02 0.91 8.95E-02 0.29
3 Atp2a2 eQTL 120 rs3724562 CEL-3_159340478 8.87E-03 1.57 7.31E-03 1.34 3.72E-03 1.14
6 Fat pQTL 27 rs13478727 rs13478839 4.24E-03 1.31 1.36E-03 1.31 2.74E-04 1.31
6 lengthNT pQTL 69 UT_6_123.37228 rs3688358 1.34E-01 0.55 7.28E-02 0.52 3.65E-02 0.43
8 AI pQTL 20 rs13479657 rs13479757 1.42E-02 1.04 5.09E-03 1.04 1.14E-03 1.04
8 Fat pQTL 20 rs13479657 rs13479757 1.15E-02 1.10 4.13E-03 1.09 9.01E-04 1.09
8 Igf2 eQTL 33 rs13479657 rs13479757 6.63E-02 1.10 3.30E-02 1.05 8.20E-01 0.01
14 BMI pQTL 63 rs3709178 rs13482404 9.57E-02 0.63 4.50E-02 0.62 1.23E-01 0.24
17 Fat pQTL 15 rs13482893 rs3719497 4.84E-02 0.74 3.38E-02 0.65 1.44E-02 0.64
17 AI pQTL 28 rs3023442 rs6395919 3.76E-02 0.83 2.68E-02 0.71 7.06E-03 0.71
17 Soleus pQTL 69 rs6257479 rs3663966 3.77E-02 0.86 1.82E-02 0.81 3.49E-02 0.45
18 AI pQTL 42 rs3718618 rs13483438 3.92E-02 0.82 2.97E-02 0.69 4.65E-02 0.39
18 Fat pQTL 42 rs3718618 rs13483438 3.27E-02 0.87 2.78E-02 0.71 4.88E-02 0.39
X Atp2a2 eQTL 54 rs13484003 rs13484087 1.74E-04 2.69 1.11E-04 2.46 1.96E-03 1.30
X Egf eQTL 56 rs13484003 rs13484087 3.34E-02 1.18 1.75E-02 1.10 1.33E-02 0.83
aTrait abbreviations are the same as in Table 1. P/D: total protein/total DNA. Atp2a2: ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 expression.
Igf2: insulin-like growth factor 2 expression. Egf: epidermal growth factor expression.
bPeak position of QTL detected in Kosambi centimorgans.
cFlanking markers (left and right) of the QTL peak. See Additional file 1: Table S6 for marker information.
dam + dm + im tested the overall interaction, which included additive, dominance, and imprinted pQTL by Myostatin genotype interactions. P-value < 0.05 is
shown in italics %var: percentage of phenotypic variance accounted for at QTL position.
eam + dm tested for non-imprinted interactions, which included additive and dominance pQTL by Myostatin genotype interactions. P-value < 0.05 is shown in
italics %var: percentage of phenotypic variance accounted for at QTL position.
fam tested for additive interactions, which included additive pQTL by Myostatin genotype interactions. P-value < 0.05 is shown in italics % var: percentage of
phenotypic variance accounted for at QTL position.
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Table 4 Statistics of QTL that interact with sex
Position Flanking markersc am + dm+ imd am + dme amf
Chr Traita Groups (cM)b Left Right P-value %var P-value % var P-value % var
1 Soleus pQTL 19 rs3696088 rs13472794 1.57E-06 2.94 3.28E-01 0.23 5.05E-01 0.05
1 Pec pQTL 23 rs3696088 rs13472794 1.23E-03 1.45 5.64E-03 0.95 7.01E-04 1.07
1 Edl pQTL 89 rs3666905 rs13476312 1.65E-02 1.03 3.48E-01 0.21 1.68E-01 0.19
2 P tQTL 34 rs6268714 rs13476554 1.18E-02 1.53 3.73E-03 1.55 2.04E-01 0.23
3 Pec pQTL 36 rs13477132 rs13477174 1.90E-02 0.99 8.37E-02 0.50 2.39E-02 0.51
3 Edl pQTL 64 rs3663873 rs13477430 4.79E-02 0.80 2.09E-02 0.78 4.70E-01 0.05
6 EGF eQTL 32 rs13478839 rs4226048 4.18E-03 1.79 2.08E-03 1.67 4.85E-04 1.64
6 Fat pQTL 10 petM-02094-1 rs3678887 3.61E-02 0.86 2.06E-02 0.78 3.46E-01 0.09
6 AI pQTL 11 petM-02094-1 rs3678887 6.05E-02 0.73 3.85E-02 0.65 5.31E-01 0.04
7 Pec pQTL 47 rs3676254 rs3656205 5.61E-03 1.25 2.84E-03 1.16 3.39E-03 0.85
9 Fat pQTL 15 rs3719607 rs8259427 2.31E-02 0.95 1.02E-02 0.92 4.53E-01 0.06
9 AI pQTL 15 rs3719607 rs8259427 3.50E-02 0.85 1.61E-02 0.82 5.38E-01 0.04
11 AI pQTL 14 rs6276300 rs6199956 3.29E-02 0.87 4.53E-02 0.62 4.35E-02 0.41
11 Fat pQTL 15 rs6276300 rs6199956 3.75E-02 0.85 4.80E-02 0.61 3.65E-02 0.44
11 Gastro pQTL 24 rs6276300 rs6199956 3.00E-04 1.90 1.77E-04 1.74 3.23E-05 1.74
11 BMI pQTL 49 rs13481054 rs3701609 1.44E-01 0.54 6.64E-02 0.54 2.85E-02 0.48
14 BMI pQTL 65 rs3709178 rs13482404 1.54E-02 1.03 1.16E-01 0.43 5.64E-01 0.03
17 Gastro pQTL 11 rs13482893 rs3719497 1.15E-01 0.59 5.29E-02 0.59 1.67E-02 0.57
17 AI pQTL 13 rs13482893 rs3719497 5.86E-02 0.73 2.56E-02 0.72 4.15E-02 0.41
17 Fat pQTL 13 rs13482893 rs3719498 4.83E-02 0.78 2.11E-02 0.77 4.19E-02 0.41
aTrait abbreviations are the same as in Table 1. P: total protein.
bPeak position of QTL detected in Kosambi centimorgans.
cFlanking markers (left and right) of the QTL peak. See Additional file 1: Table S6 for marker information.
dam + dm + im tested the overall interaction, which included additive, dominance, and imprinted pQTL by sex interactions. P-value < 0.05 is shown in italics %var:
percentage of phenotypic variance accounted for at QTL position.
eam + dm tested for non-imprinted interactions, which included additive and dominance pQTL by sex interactions. P-value < 0.05 is shown in italics %var:
percentage of phenotypic variance accounted for at QTL position.
fam tested the additive interaction, which included additive pQTL by sex interactions. P-value < 0.05 is shown in italics %var: percentage of phenotypic variance
accounted for at QTL position.
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interactions is summarized in Figure 2(B). For fat-related
traits, pQTL by Myostatin genotype or sex interactions
explained the majority of the phenotypic variation. In
contrast, pQTL by cross interactions explained more of
the phenotypic variation in muscle weight traits. Inter-
estingly, no pQTL interactions were identified for body
length traits. Overall, the amount of phenotypic vari-
ation that could be accounted for by QTL interactions
was very small for tQTL and eQTL traits.
Discussion
Imprinting effects on body size and adipose traits
We identified six imprinted QTL. The reason we were
able to detect these imprinted QTL was because the two
mouse lines used in this study were not fully inbred. In
mice, a few imprinted QTL have been previously identi-
fied. For example, Leamy et al. [41] used a post hoc t-
test [6] from regression analyses and discovered several
QTL that displayed an imprinted inheritance pattern formandible size and shape in mice. These QTL were
located on chromosomes 2, 3, 6, and 12. Imprinted QTL
have also been identified on mouse chromosome 8 for a
mature body mass trait [42]. In addition, there was
evidence to support the possibility that some imprinted
genomic regions on mouse chromosomes 3, 4, 5, 6, 7,
12, 18 and 19 had effects on adult body composition and
muscle traits [43-45]. Based on these previous mapping
results, chromosomes 10 and 11 have not been previ-
ously shown to harbor QTL that influence body length
traits.
The imprinted QTL identified on chromosome 18 was
associated with fat-related traits. This region has not been
previously identified as potentially harboring imprinted
QTL in other studies, likely due to the limited amount of
research conducted to identify imprinted QTL that influ-
ence adipose accumulation. In mice, potential imprinted
obesity QTL were first identified in LGXSM recombinant
inbred strains [46]. Although this imprinting effect
may confound with maternal effect. Other studies provide
Table 5 Statistics of QTL that interact with reciprocal cross
Position Flanking markersc am + dm+ imd am+ dme amf
Chr Traita Groups (cM)b Left Right P-value % var P-value % var P-value % var
1 Gastro pQTL 23 rs3696088 rs13472794 2.85E-06 2.68 4.41E-06 2.32 3.14E-06 2.06
1 Pec pQTL 23 rs3696088 rs13472794 1.62E-02 0.94 7.04E-02 0.49 5.78E-03 0.71
1 Tnni1 eQTL 24 rs3696088 rs13472794 3.03E-02 1.14 1.25E-02 1.12 4.84E-03 1.02
1 Edl pQTL 25 rs3696088 rs13472794 4.02E-04 1.81 8.59E-03 0.95 4.14E-03 0.82
1 R tQTL 29 rs13472794 rs13475931 1.09E-05 3.50 2.03E-02 1.09 1.10E-01 0.36
1 R/D tQTL 29 rs13472794 rs13475931 1.39E-04 2.82 1.81E-02 1.12 1.65E-01 0.27
6 lengthNA pQTL 63 mCV24115224 UT_6_123.37228 3.24E-02 0.87 5.46E-02 0.58 2.81E-02 0.48
7 Pec pQTL 47 rs3676254 rs3656205 3.82E-02 0.84 1.64E-02 0.82 1.25E-01 0.24
7 IGF1 eQTL 53 rs13479422 rs13479471 1.62E-02 1.33 6.47E-03 1.31 5.18E-03 1.02
7 Tail pQTL 61 rs13479471 rs6275579 3.45E-02 0.86 5.23E-01 0.13 6.42E-01 0.02
11 Fat pQTL 57 rs3701609 rs8270290 5.27E-02 0.77 1.76E-02 0.81 8.18E-02 0.31
11 AI pQTL 57 rs3701609 rs8270290 6.46E-02 0.72 2.18E-02 0.76 1.06E-01 0.26
13 R tQTL 25 rs13481780 rs3678784 1.08E-03 2.21 2.08E-04 2.34 1.26E-03 1.44
13 R/D tQTL 25 rs13481780 rs3678784 2.05E-03 2.02 4.71E-04 2.12 4.36E-03 1.13
14 R/D tQTL 18 rs13482096 rs8251329 3.64E-04 2.56 6.77E-04 2.03 1.05E-03 1.50
17 Edl pQTL 31 rs3023442 rs6395919 2.00E-01 0.47 9.81E-02 0.47 3.46E-02 0.45
aTrait abbreviations are the same as in Table 1. R: total RNA; R/D: total RNA/total DNA.
bPeak position of QTL detected in Kosambi centimorgans.
cFlanking markers (left and right) of the QTL peak. See Additional file 1: Table S6 for marker information.
dam + dm + im tested the overall interaction, which included additive, dominance, and imprinted pQTL by cross interactions. P-value < 0.05 is shown in italics
% var: percentage of phenotypic variance accounted for at QTL position.
eam + dm tested for non-imprinted interactions, which included additive and dominance pQTL by cross interactions. P-value < 0.05 is shown in italics % var:
percentage of phenotypic variance accounted for at QTL position.
fam tested for additive interactions, which included additive QTL by cross interactions. P-value < 0.05 is shown in italics %var: percentage of phenotypic variance
accounted for at QTL position.
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chromosomes 2 and 7 that are associated with fat pad
weight in mice [47]. Imprinted obesity QTL in other
species, such as humans and pigs [48-50], also indicate
that imprinted QTL can account for significant amounts
of the variation observed in muscle mass and fat depos-
ition traits.
pQTL control of muscle and adipose traits
Using interval mapping and the genome-wide permuta-
tion method, we identified a number of additive and
dominance pQTL that were associated with muscle
weight and fat-related traits. This is understandable
given the mouse lines used in this study. The most
significant phenotypic differences observed between M16i
and C57BL/6 Myostatin-null lines were in skeletal muscle
weight and fat accumulation. We expected that loci
associated with these phenotypes would segregate in the
F2 generation and could be identified through pQTL
mapping. Most of the estimated QTL effects were small.
These results support our current understanding of
genomic architecture, in that quantitative traits are con-
trolled by numerous genes each with small effects, as well
as a few genes with large effects.The chromosomes that were associated with signifi-
cant pQTL effects contained some promising candidate
genes for muscle, adipose, and body size development.
For example, IGF-binding protein 2 (Igfbp2), located at
36 cM on chromosome 1, has been shown to modulate
IGF1 activity and thereby protect against obesity [51].
This is in close proximity to our fat QTL at 24 cM on
chromosome 1. In close proximity to Igfbp2, IGF-
binding protein 5 (Igfbp5) on chromosome 1 is another
candidate gene which is known to impact whole-body
growth and muscle development [52]. On chromosome
7, the insulin-like growth factor 1 receptor gene (IGF1r)
at 33 cM could be the gene underlying our muscle QTL
at 47 cM on the same chromosome. The growth hor-
mone gene (Gh) at 65 cM on chromosome 11is located
close to the position of our gastrocnemius QTL at
68 cM. Variants in these genes have been associated with
overgrowth [53], obesity [54] and insulin resistance [55],
which could have more widespread effects for other
tissues, e.g. skeletal muscle growth.
Some of the pQTL that were associated with AI and fat
weight overlapped with one another (see Table 1). This
finding is not unexpected, given the high positive pheno-
typic correlation between these two traits. However, the
Figure 2 Proportion of phenotypic variation accounted for by identified QTL. (A) Phenotypic variation accounted for by additive,
dominance and imprinted QTL effects. interaction: the sum of Myostatin genotype by QTL, reciprocal cross by QTL, and sex by QTL effect.
vi: imprinted QTL effect. vd: dominance QTL effect. va: additive QTL effect. (B). Phenotypic variation accounted for by QTL that interacted with
Myostatin genotype, reciprocal cross, and sex. Trait abbreviations are the same as in Table 1. Mstn: Myostatin genotype by QTL interaction.
Cross: Reciprocal cross by QTL interaction. Sex: Sex by QTL interaction.
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associated with either AI or fat weight. pQTL for fat-
related traits (e.g., body fat mass and body mass) have
been mapped to this region previously [56-58]. The fact
that BMI, AI, and fat weight pQTL were not identical sup-
ports the importance of using multiple measurements of
obesity. BMI was first described in the 19thcentury and
has been widely used in clinical obesity research. BMI
takes into account body size information that might not
be elucidated by AI and fat weight measurement alone.
Identification of genetic variants that are associated with
BMI at different growth periods should help to under-
stand the genetic mechanisms that underlie BMI
[57,59-61].Inheritance pattern of QTL that interact with Myostatin
genotype, reciprocal cross and sex
We tested the identified pQTL for possible interactions
with Myostatin genotype, reciprocal cross, and sex. In
addition, we evaluated the nature of the inheritance
pattern of these pQTL interactions (i.e., additive, domin-
ance, or imprinted) by comparison of different QTL
models. For example, many of the QTL that interacted
with Myostatin genotype, reciprocal cross, and sex
appeared to be inherited in either an additive (e.g., the
gastrocnemius weight pQTL on chromosome 17 that
interacted with sex; Table 4) or dominant (e.g., the fat
pad weight pQTL on chromosome 11 that interacted
with reciprocal cross; Table 5) fashion. Meanwhile, there
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interaction effect (am) or combination interaction effect
(am + dm), but that were potentially inherited in an
imprinted manner (e.g., the EDL weight pQTL on
chromosome 1 that interacted with sex; Table 4). These
statistical testing results indicate that the interaction pat-
tern between a given QTL and Myostatin genotype,
cross, or sex is complicated, and further molecular
experiments with these loci will be needed in order to
elucidate the inheritance pattern.
We estimated the phenotypic variation accounted for by
the identified QTL. Compared to additive and dominant
QTL effects, individual interactions generally explained a
small proportion of the total phenotypic variation (<2% of
the total). In our previous pQTL mapping study [12], we
discovered a number of QTL interactions that also ex-
plained a small amount of phenotypic variation in growth
traits. These results indicate that, for quantitative traits,
the amount of variation explained by gene-gene interac-
tions appears to be smaller than for additive and dominant
QTL. However, in this study, we only evaluated QTL by
Myostatin genotype, which is a small proportion of the
possible gene-gene interactions. Thus, the total amount of
phenotypic variation explained by these gene-gene inter-
actions could still be large if all possible gene-gene interac-
tions within the genome were accounted for.
Integration of tQTL, eQTL, and pQTL information
Three tQTL on chromosomes 1, 13, and 14 significantly
interacted with cross to affect the total RNA amount
and RNA/DNA ratio in the pectoralis. RNA/DNA ratio
is a rough measure of transcriptional rate. Therefore, it
would appear that there are some alleles that segregate
between these two lines that control overall transcription
level. Two other tQTL on chromosome 2 were associ-
ated with total protein amount and the protein/DNA
ratio (Tables 3 and 4). These two tQTL significantly inter-
acted with Myostatin genotype and sex. The amount of
protein and protein/DNA ratio in a tissue are indicators of
muscle hypertrophy, which is known to result when
Myostatin is postnatally inactivated in mice [62]. There-
fore, these two QTL could be key mediators of protein
accretion that are controlled by Myostatin and sex to
regulate muscle hypertrophy.
It has been demonstrated that IGF1 regulates skeletal
muscle growth by promotion of satellite cell prolifera-
tion and muscle protein synthesis [63,64]. Previously, we
reported that the genomic region surrounding 65 cM on
chromosome 4 was significantly associated with average
daily gain (from the 1st to 3rd week) and body weight
(the 3rd, 4th, and 5th week) traits (Cheng et al., 2011).
Here, we identified an eQTL for IGF1 expression at
68 cM on chromosome 4. Considering that the IGF1
gene is located on mouse chromosome 10, these resultsindicate that it is highly possible that a trans-regulatory
element of IGF1 expression is located on chromosome
4. This element might control the expression level of
IGF1 to further regulate body growth. In addition, an-
other IGF1 eQTL was identified on chromosome 7 that
significantly interacted with reciprocal cross (Table 5). In
addition, we detected muscle pQTL that also interacted
with cross and sex near this position (Tables 4 and 5).
These results support the possibility that in addition to
genetic background, IGF1 contributes to the sexual di-
morphism in whole body weight and muscle growth,
likely via GH and the Stat5b signaling pathway [65,66].
We evaluated the positional concordance between
pQTL and eQTL. Amongst them, we observed a re-
markable co-localization of pectoralis and gastrocnemius
weight pQTLs on chromosome 1 (23 cM) and a cis-act-
ing eQTL regulating the expression levels of Tnni1.
Tnni1 gene is associated with tropomyosin and regulates
the calcium sensitivity of the myofibril contractile appar-
atus of striated muscles.
We identified two eQTL that interacted with Myosta-
tin genotype to control Atp2a2 expression level. These
two eQTL were not located on the same chromosome as
Atp2a2 and might be long-distance regulatory factors.
Recently, it was shown that a change in Atp2a2expres-
sion level was representative of a fiber-type transform-
ation [67]. In addition, proteomic analysis of skeletal
muscle in cattle demonstrated that Myostatin genotype
impacted muscle fiber composition [68]. Thus, it is
possible that Myostatin might interact with these two
eQTL to regulate the Atp2a2 activity, thereby altering
fiber type.
Conclusions
Imprinted pQTL were identified on chromosomes 6, 9,
10, 11, and 18 that were associated with muscle weight,
fat-related, and body length traits. Furthermore, pQTL,
tQTL, and eQTL that interacted with Myostatin genotype,
reciprocal cross, and sex were identified across the gen-
ome. These results indicate that gene-gene interactions
are widely involved in muscle and adipose development.
Methods
Mouse lines and breeding procedure
Two founder mouse strains, Myostatin-null C57BL/6 [69]
and M16i high body weight [34], were reciprocally crossed
to derive an F2 mapping population. The Myostatin-null
C57BL/6 line contained a non-functional Myostatin gene
on both chromosomes. The M16i obese mouse line was
derived from an outbred population (ICR) for high weight
gain prior to six weeks of age. To generate the F2 progeny,
four Myostatin-null male mice were crossed with eight
M16i females. This generated 35 male and 37 female F1
mice. Meanwhile, two M16i males and seven Myostatin-
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31 male and 55 female F1 offspring. The resulting F1 mice
were intercrossed within each reciprocal cross to obtain
the final F2 mapping population.
Trait collection procedures
One day after birth, each F2 litter was standardized to
nine pups. Mice were identified by toe clipping seven
days after birth. At three weeks of age, mice were
weaned and placed in separate cages. We obtained 552
mice from the Myostatin-null male by M16i female cross
and 448 mice from the reciprocal cross. These 1,000 F2
mice were either homozygous Myostatin wild-type or
homozygous Myostatin-null genotype. At 42 days of age,
body weight was recorded for each F2 individual. Subse-
quently, mice were sacrificed. Skeletal muscles (soleus,
gastrocnemius, EDL, and pectoralis) from both the left
and right sides of the body, as well as gonadal fat pads
(epididymal for males and perimetrial for females) were
collected and weighed. The tissue weight percentage was
calculated as the percentage of tissue weight divided by
the 6th week body weight. Body size traits (nasal-tail
length, nasal-anal length, and tail length) were also mea-
sured. Based on these measurements, body mass index
(BMI) and adiposity index (AI) were calculated and
included as measurements of obesity [70]: BMI = 6th week
body weight / square of the anal-nasal length; AI = 6th
week body weight / fat weight. All weights were measured
in grams (g), while all lengths were measured in centime-
ters (cm).
A proportion of the right pectoralis muscle of each F2
mouse was used for total RNA, DNA, and protein isola-
tion using a standard protocol [71]. For tQTL mapping,
the ratios of DNA/RNA, protein/RNA and protein/DNA
were calculated based on these measurements. The
remainder of the muscle was homogenized in liquid
nitrogen. After homogenization, total RNA was isolated
using RNeasy (Qiagen). The resulting RNA was ampli-
fied and measured by a triplex qPCR using Quantitect
(Qiagen). Three sets of triplex qPCR assays were per-
formed. The first set included beta-actin (Actb), adipo-
philin (Adfp) and ATPase2 (Atp2a2). The second set
included epidermal growth factor (Egf ), insulin-like
growth factor 1 (IGF1) and insulin-like growth factor 2
(Igf2). The third set included myogenic factor 5 (Myf5),
troponinI (Tnni1) and wingless-related MMTV integra-
tion site 4 (Wnt4). qPCR primers are listed in Additional
file 1: Table S5. Each sample was measured twice, and
the average CT value was then normalized by the CT
value of Actb and by the plate efficiency. The adjusted
CT values were then used as traits for eQTL mapping.
All animal procedures were approved by the Iowa State
University Animal Care and Use Committee prior to
this study.Genotyping and linkage map
Genomic DNA was isolated from toe clips and purified by
a phenol chloroform method. A total of 242 SNPs evenly
spaced across19 autosomes and the X chromosome were
genotyped on the 1,000 F2 mice, in addition to the Myos-
tatin locus. The Myostatin locus was genotyped by stand-
ard PCR and agarose gel electrophoresis protocols. The
SNP genotyping procedure was performed on the Seque-
nom® platform at GeneSeek® (Lincoln, Nebraska). SNPs on
chromosome 15 and chromosome 16 were discarded
because no informative SNPs were present. Among the
remaining SNPs, 152 SNPs with call rates greater than
80% and no observable genotyping errors were included
in the analysis. These 152 SNPs were located on 17 auto-
somes and the X chromosome. Marker segregation distor-
tion was evaluated in the F2 mice by a chi-square test.
Only SNPs close to the Myostatin locus significantly devi-
ated from the expected Mendelian segregation ratios. This
was caused by the fact that only homozygotes at the Myos-
tatin locus were included. All 152 SNP markers were used
to generate a linkage map by CRIMAP [72], with distances
estimated in Kosambi centimorgans. The marker order
and position in our map (Additional file 1: Table S6) were
consistent with the map from the Wellcome-CTC Mouse
Strain SNP Genotype Set. Therefore, we analyzed the data
based on our linkage map.
Data analyses
Data exploration
Simple statistics (mean, standard deviation, minimum and
maximum) were calculated for each trait. In addition, all
main factors (Myostatin genotype, sex, reciprocal cross,
coat color) and interaction terms (interactions between
main effects) were tested for each trait by fitting a gene-
ralized linear model. Effects with a P-value of less
than 0.1 were included in the QTL model (Additional
file 1: Table S3). Significant factors were removed from
the linear model to evaluate the residual correlations
between each pair of trait values. All general statistical
analyses of the F2 data were carried out using a SAS® soft-
ware package. The corresponding procedures used were
PROCMEANS, PROCGLM and PROCCORR.
Additive, dominance, and imprinting effects
First, we analyzed each trait to identify imprinted QTL.
To achieve this, two different models were used to per-
form a whole-genome scan. The imprinted QTL model
included significant main effects and interaction effects,
along with additive, dominance, and parent-of-origin
(imprinting) effects at a single QTL position. The non-
imprinted QTL model included all the terms in the first
model except for the imprinting effect. Each QTL model
was individually analyzed in GridQTL [73], a web-based
QTL analysis program to identify QTL by interval
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with 1,000 repetitions was applied to each model to
obtain 1% and 5% genome-wide significance levels. All
QTL positions above the 5% significance level under the
imprinted QTL model and the non-imprinted QTL
model were used to evaluate the imprinting effect by
calculating an F-value as follows:
F
ΔSSE
SSE imprintedQTLmodelð Þ=d:f : imprintedQTLmodelð Þ
ΔSSE¼SSE non‐imprintedQTLmodelð Þ‐SSE impritedQTLmodelð Þ
d.f. : degree of freedom of error term (same after)
SSE : sum squares of error
The corresponding comparison-wise P-value was com-
puted from a standard F-distribution with the correspond-
ing degrees of freedom. If the P-value was less than 0.05,
the imprinted QTL model was assumed to be more suit-
able for this QTL position. Otherwise, the non-imprinted
model was chosen. After the best model for each trait was
determined, it was applied to each QTL position again to
obtain F-values, LOD scores and estimates for QTL
effects, along with the corresponding standard errors for
each QTL peak.
At each QTL position, a corresponding comparison-
wise P-value was computed for the additive and domin-
ance effects respectively, as follows:
Additive and dominance model (AD model):
Phenotypic value¼ fixed effectsþadditive effect
 QTLpositionð Þ
þdominanceeffect QTLpositionð Þþε
Additive model (A model):
Phenotypic value¼fixed effectsþadditive effect
 QTLpositionð Þþε
Full reduced model (R model):
Phenotypic value ¼ fixed effects þ ε
For additive effect:
F¼ SSE R modelð Þ‐SSE A modelð Þ
SSE Amodelð Þ=d:f : Amodelð Þ
For dominance effect:
F¼ SSE A modelð Þ‐SSE AD modelð Þ
SSE AD modelð Þ=d:f : ADmodelð Þ
We calculated P-values from an F-distribution with
the corresponding degrees of freedom. We named this
P-value as a comparison-wise P-value.The phenotypic variance explained by the QTL was
computed. For imprinted QTL, the percentage of pheno-
typic variation accounted for by a QTL position was
computed as the percentage of residual sum of squares
explained by the additive, dominance, and imprinting
effects at the QTL using the imprinted QTL model. For
non-imprinted QTL, the percentage of phenotypic vari-
ation accounted for by a QTL position was computed as
the percentage of residual sum of squares explained by
the additive and dominance effects using the non-
imprinted QTL model.
QTL interaction analysis
We first analyzed the interaction between QTL position
and Myostatin genotype. To accomplish this, we split the
data into two subsets based on Myostatin genotype.
Within each Myostatin genotype subset, both the imprin-
ted QTL model and the non-imprinted QTL model were
evaluated by interval mapping. All QTL positions
identified at 5% genome-wide significance levels in
either model were considered for analysis in the next
step, in which the following six QTL models were
fitted to these identified QTL positions in the full F2
dataset.
Model 1–1:









Phenotypic value ¼ fixed effectsþ additiveeffect
 QTLpositionð Þ þ dominanceeffect
 QTLpositionð Þ þ imprinting effect
 QTLpositionð Þ þ ε
Model 2–1:
Phenotypic value¼ fixed effectsþadditive effect
 QTLpositionð Þþdominanceeffect
 ðQTLpositionÞþMyostatin
additive effect QTLpositionð Þ
þMyostatindominance effect
 QTLpositionÞþεð
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Phenotypic value¼ fixed effectsþadditiveeffect
 QTLpositionð ÞþMyostatin
additive effect QTLpositionð Þþε
Model 3–2:
Phenotypic value¼ fixed effectsþadditive effect
 QTLpositionð Þþε
By comparing the above models, we determined the
F-values for different interaction effects as follows:
1) When considering the general interaction
(additive, dominance and imprinting interaction):
F
ΔSSE=3
SSE model 1−1ð Þ=d:f : model 1−1ð Þ
ΔSSE ¼ SSE model 1−2ð Þ−SSE MODEL2−1ð Þ
2) When considering the non-imprinting interaction
(additive and dominance interaction):
F ¼ ΔSSE=3
SSE model2−1ð Þ=d:f model 1−1ð Þ
ΔSSE ¼ SSE model 2−2ð Þ−SSE model 2−1ð Þ
3) When considering the additive interaction:
F ¼ ΔSSE
SSE model 3−1ð Þ=d:f : model 3−1ð Þ
ΔSSE ¼ SSE model 3−2ð Þ−SSE model 3−1ð Þ
Correspondingly, each F-value gave a comparison-wise
P-value. Interactions with a P-value of less than 0.05
were considered significant.
Using a similar approach, reciprocal cross × QTL in-
teractions were analyzed. Initially, the data was split into
two subsets by reciprocal crosses and potential QTL po-
sitions for testing. Reciprocal cross interactions were
identified within each cross subset. Then, interactions at
each position were tested in the full dataset, similar to
the procedure used for Myostatin interactions, but with
the Myostatin effect replaced by the reciprocal cross
effect in models 1–1 to 3–2.
Finally, the same approach was applied to identify
sex × QTL interactions. The data was split into two sub-
sets by sex and potential QTL positions were identifiedwithin each sex subset. Myostatin effect in the QTL
models was replaced by sex effect, and the correspond-
ing interaction effects were switched, as well.
Estimates of additive and dominance effects and
phenotypic variation accounted for by each identified
QTL were estimated in the same way discussed above
for main effect QTL. To calculate the total effect of
pQTL, we summed the phenotypic variation explained
by all main effect pQTL and interaction pQTL, for each
trait respectively.
Additional files
Additional file 1: Includes Table S1 to Table S6, which give detail
information about the statistical summary of traits measured in this
study, the estimated effects of identified QTLs and SNP markers.
Additional file 2: Includes Table S7, which gives detail information
about pairwise correlation among all traits measured in this study.
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